版本:
中国

BRIEF-Leap Therapeutics reports qtrly net loss per share $1.39

May 12 Leap Therapeutics Inc:

* Leap Therapeutics reports first quarter 2017 financial results

* Leap Therapeutics Inc - net loss was $9.4 million for Q1 of 2017, compared to $5.1 million for same period in 2016

* Leap Therapeutics Inc - cash, cash equivalents and marketable securities totaled $23.8 million at March 31, 2017

* Leap Therapeutics Inc qtrly net loss per share $1.39

* Leap Therapeutics Inc - research and development expenses were $6.4 million for Q1 2017, compared to $4.1 million for same period in 2016 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐